|
|||||
|
|
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor–positive,human epidermal growth factor receptor 2–negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013 |
|
| Authors: | Dan Le MD MHA Caroline Speers BA Leigh Thompson BSc Lovedeep Gondara MS Alan Nichol MD Caroline Lohrisch MD |
| Institution: | 1. Department of Medical Oncology, Fraser Valley Cancer Centre, BC Cancer, Surrey, British Columbia, Canada;2. Cancer Surveillance and Outcomes, BC Cancer, Vancouver, British Columbia, Canada;3. Department of Radiation Oncology, Vancouver Centre, BC Cancer, Vancouver, British Columbia, Canada;4. Department of Medical Oncology, Vancouver Centre, BC Cancer, Vancouver, British Columbia, Canada |
| Abstract: | |
| Keywords: | duration of treatment hormonal therapy hormone receptor–positive metastatic breast cancer survival systemic therapy |